Immunogen Inc SVP & CHIEF BUSINESS OFFICER Stacy Coen Sells 4,583 Shares
On February 5, 2024, Stacy Coen, SVP & CHIEF BUSINESS OFFICER of Immunogen Inc, executed a sale of 4,583 shares of the company.
Source: yahoo.com
Stacy Coen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stacy Coen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stacy Coen Today - Breaking & Trending Today
Insider Sell: SVP & Chief Business Officer Stacy Coen Sells 108,609 Shares of Immunogen Inc ...
In a notable insider transaction, Stacy Coen, the Senior Vice President & Chief Business Officer of Immunogen Inc (NASDAQ:IMGN), sold 108,609 shares of the company on November 17, 2023.
Source: yahoo.com
ImmunoGen, OBT partner to develop new antibody-drug conjugates
ImmunoGen and OBT have entered into a multi-year research collaboration to develop new antibody-drug conjugates (ADCs) to treat cancers.
Oxford BioTherapeutics Announces Research Collaboration with ImmunoGen to Develop Novel Antibody-Drug Conjugates
Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies, today announced a multi-year collaboration to research, develop and commercialize novel, first-in-class ADCs with ImmunoGen (IMGN), a leader in the expanding field of ...
Source: pharmiweb.com
Oxford BioTherapeutics Announces Research Collaboration with ImmunoGen to Develop Novel Antibody-Drug Conjugates
/PRNewswire/ -- Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based...
Source: prnewswire.com